phentolamine has been researched along with Pancreatic Neoplasms in 5 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report series describes eight patients (four patients with pancreatic carcinoma, one patient with hepatocellular carcinoma, one patient with gastric and rectal carcinoma, one with sigmoid colon cancer, and one with rectal cancer), whose abdominal cancer pain was treated with intravenous phentolamine infusion at 80 mg x day(-1) for 2 days." | 7.74 | Intravenous phentolamine infusion alleviates the pain of abdominal visceral cancer, including pancreatic carcinoma. ( Kamiizumi, Y; Yasukawa, K; Yasukawa, M; Yokoyama, R, 2007) |
| "This case report describes the successful alleviation of the pain of pancreatic carcinoma with intravenous phentolamine mesylate." | 7.69 | Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma. ( McCleane, GJ, 1997) |
| "This case report series describes eight patients (four patients with pancreatic carcinoma, one patient with hepatocellular carcinoma, one patient with gastric and rectal carcinoma, one with sigmoid colon cancer, and one with rectal cancer), whose abdominal cancer pain was treated with intravenous phentolamine infusion at 80 mg x day(-1) for 2 days." | 3.74 | Intravenous phentolamine infusion alleviates the pain of abdominal visceral cancer, including pancreatic carcinoma. ( Kamiizumi, Y; Yasukawa, K; Yasukawa, M; Yokoyama, R, 2007) |
| "This case report describes the successful alleviation of the pain of pancreatic carcinoma with intravenous phentolamine mesylate." | 3.69 | Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma. ( McCleane, GJ, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RUNGE, TM | 1 |
| Yasukawa, M | 1 |
| Yasukawa, K | 1 |
| Kamiizumi, Y | 1 |
| Yokoyama, R | 1 |
| Hirose, H | 1 |
| Seto, Y | 1 |
| Maruyama, H | 1 |
| Dan, K | 1 |
| Nakamura, K | 1 |
| Saruta, T | 1 |
| McCleane, GJ | 1 |
| Chapman, JC | 1 |
| McClenaghan, NH | 1 |
| Cosgrove, KE | 1 |
| Hashmi, MN | 1 |
| Shepherd, RM | 1 |
| Giesberts, AN | 1 |
| White, SJ | 1 |
| Ammälä, C | 1 |
| Flatt, PR | 1 |
| Dunne, MJ | 1 |
5 other studies available for phentolamine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phentolamine (regitine) methanesulfonate test in pancreatic adenoma.
Topics: Adenoma; Mesylates; Pancreatic Neoplasms; Phentolamine; Sympatholytics | 1958 |
Intravenous phentolamine infusion alleviates the pain of abdominal visceral cancer, including pancreatic carcinoma.
Topics: Abdominal Pain; Aged; Analgesics, Non-Narcotic; Carcinoma; Digestive System Neoplasms; Female; Gastr | 2007 |
Effects of alpha 2-adrenergic agonism, imidazolines, and G-protein on insulin secretion in beta cells.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agon | 1997 |
Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma.
Topics: Adult; Analgesics, Non-Narcotic; Humans; Infusions, Intravenous; Male; Pain; Pancreatic Neoplasms; P | 1997 |
ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Benzofurans; C | 1999 |